Safilo Group SpASAFLF 62 Market Cap is $763 Mil as of Jun. 26, 2026. GuruFocus rates SAFLF with a GF Score™ of 62/100 and a GF Value™ of $1.23 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Safilo Group SpA ranks better than 76.44% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Safilo Group SpA's share price for the quarter that ended in Dec. 2025 was $2.2. Safilo Group SpA's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 392 Mil. Therefore, Safilo Group SpA's market cap for the quarter that ended in Dec. 2025 was $862 Mil.
Safilo Group SpA's quarterly market cap
declined
from Dec. 2024 ($395 Mil) to Jun. 2025 ($308 Mil) but then
increased
from Jun. 2025 ($308 Mil) to Dec. 2025 ($862 Mil).
Safilo Group SpA's annual market cap
increased
from Dec. 2023 ($379 Mil) to Dec. 2024 ($395 Mil) and
increased
from Dec. 2024 ($395 Mil) to Dec. 2025 ($862 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Safilo Group SpA's Enterprise Value for Today is $828 Mil.
Safilo Group SpA (OTCPK:SAFLF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Safilo Group SpA Market Cap Related Terms
Safilo Group SpA Market Cap Historical Data
* Premium members only.
The historical data trend for Safilo Group SpA's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Safilo Group SpA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Safilo Group SpA Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Safilo Group SpA's Market Cap distribution charts can be found below:
* The bar in red indicates where Safilo Group SpA's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Safilo Group SpA's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Safilo Group SpA (SAFLF) has a Market Cap of $763 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Safilo Group SpA and its competitors. According to the industry distribution chart, Safilo Group SpA ranks #204 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 23.6%.
Is Safilo Group SpA's Market Cap too high?
Safilo Group SpA's current Market Cap is $763 Mil. The Medical Devices & Instruments industry median Market Cap is 121.29. Safilo Group SpA's value of $763 Mil is 529.1% above this industry median. Based on the distribution chart, Safilo Group SpA ranks #204 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Safilo Group SpA has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Safilo Group SpA's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Safilo Group SpA ranks #204 out of 866 companies for Market Cap. This places Safilo Group SpA in the top 24% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.29. Safilo Group SpA's value of $763 Mil is 529.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.29, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Safilo Group SpA's current Market Cap of $763 Mil is 529.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Safilo Group SpA and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Safilo Group SpA's current Market Cap is $763 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Safilo Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Safilo Group SpA (SAFLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.23, compared to a current price of $2.01 — trading 63.4% above its estimated fair value. The current Market Cap is $763 Mil and 529.1% above the Medical Devices & Instruments industry median of 121.29. Safilo Group SpA's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Safilo Group SpA (SAFLF), the current Market Cap is $763 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Safilo Group SpA (SAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Safilo Group SpA stock appears to be overvalued.
The current stock price of $2.01 is trading 63.4% above its estimated GF Value™ of $1.23.
GuruFocus considers Safilo Group SpA to be Significantly Overvalued.
Key valuation signals for SAFLF:
Market Cap: $763 Mil
GF Value™: $1.23 vs. price of $2.01 (63.4% above fair value)
Industry Position: 529.1% above the Medical Devices & Instruments median (#204 of 866)
No single metric tells the full story. See the SAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Safilo Group SpA makes sunglasses and prescription eyewear. It is engaged in design, production, and wholesale distribution of its products through a network of independent distributors and commercial subsidiaries. Its products are sold through the Carrera, Smith, Polaroid and Oxydo brands, as well as a range of other licensed brands. The company operates solely through the wholesale segment channels and divides itself into the following four geographical segments: Europe, America, and Asia. The company earns the majority of its revenue from the Europe business segment.
62GF Score
Get the complete analysis for SAFLF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAFLF has been successfully added to your 
